The expression of CD71 is consistent with an erythroid differentiation of blasts in a case of leukemia treated with gilteritinib, which is in agreement with a recent study32, and contrasts with a prior report of gilteritinib-induced terminal differentiation towards a myeloid fate31. Here, TFRC is linked to leukemia.